Home/Publication/Cowin Doubles Down on Flu Antivirals Developer
Cowin Doubles Down on Flu Antivirals Developer 

27 Jun 2024

US$ 19.00

Cowin Capital has made a follow-on investment in the over Rmb200 million (US$27.5 million) series A funding round of ......

Price / article: US$19.00
OR existing subscriber
Related Publications

Siguler Guff & Co LP has joined Creador to take an aggregate 10% interest in La Renon Healthcare Pvt Ltd ......

MBK Partners Ltd (MBK) is said to have closed its MBK Partners Fund VI LP at US$5.5 bn, according to various ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.